Healthcare provider profile · identity verified

Sean P Mccall, D.O.

Internal Medicine · SCRANTON, PA · NPI 1780668533

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	814	238
Lisinopril	Lisinopril	504	141
Levothyroxine Sodium	Levothyroxine Sodium	439	105
Metoprolol Succinate	Metoprolol Succinate	398	110
Omeprazole	Omeprazole	388	118
Rosuvastatin Calcium	Rosuvastatin Calcium	386	118
Amlodipine Besylate	Amlodipine Besylate	373	97
Losartan Potassium	Losartan Potassium	261	74
Gabapentin	Gabapentin	253	64
Jardiance	Empagliflozin	243	49
Alprazolam	Alprazolam	211	34
Famotidine	Famotidine	195	60
Furosemide	Furosemide	189	56
Albuterol Sulfate Hfa	Albuterol Sulfate	184	67
Metformin Hcl	Metformin Hcl	178	54
Eliquis	Apixaban	171	35
Metformin Hcl Er	Metformin Hcl	162	47
Pantoprazole Sodium	Pantoprazole Sodium	156	44
Ezetimibe	Ezetimibe	153	40
Carvedilol	Carvedilol	146	34
Metoprolol Tartrate	Metoprolol Tartrate	136	33
Ozempic	Semaglutide	136	30
Simvastatin	Simvastatin	131	38
Allopurinol	Allopurinol	130	35
Fluticasone Propionate	Fluticasone Propionate	125	40
Lorazepam	Lorazepam	124	24
Baclofen	Baclofen	115	42
Tamsulosin Hcl	Tamsulosin Hcl	115	39
Trazodone Hcl	Trazodone Hcl	112	28
Glimepiride	Glimepiride	104	27
Sertraline Hcl	Sertraline Hcl	101	32
Tramadol Hcl	Tramadol Hcl	101	21
Montelukast Sodium	Montelukast Sodium	100	32
Duloxetine Hcl	Duloxetine Hcl	99	22
Clopidogrel	Clopidogrel Bisulfate	92	30
Prednisone	Prednisone	92	50
Topiramate	Topiramate	92	14
Clonazepam	Clonazepam	89	15
Azithromycin	Azithromycin	87	54
Hydrochlorothiazide	Hydrochlorothiazide	86	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	11
Ondansetron Hcl	Ondansetron Hcl	81	28
Warfarin Sodium	Warfarin Sodium	81	21
Citalopram Hbr	Citalopram Hydrobromide	74	18
Fluoxetine Hcl	Fluoxetine Hcl	74	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	12
Valsartan	Valsartan	70	18
Potassium Chloride	Potassium Chloride	65	15
Pravastatin Sodium	Pravastatin Sodium	64	15
Hydroxyzine Hcl	Hydroxyzine Hcl	58	17
Atenolol	Atenolol	57	17
Celecoxib	Celecoxib	56	16
Irbesartan	Irbesartan	56	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	16
Venlafaxine Hcl Er	Venlafaxine Hcl	55	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	54	17
Ibuprofen	Ibuprofen	52	11
Oxycodone Hcl	Oxycodone Hcl	52	suppressed
Amoxicillin	Amoxicillin	48	31
Tradjenta	Linagliptin	48	suppressed
Xarelto	Rivaroxaban	48	suppressed
Alendronate Sodium	Alendronate Sodium	47	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	12
Escitalopram Oxalate	Escitalopram Oxalate	44	12
Mirtazapine	Mirtazapine	44	11
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Trulicity	Dulaglutide	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	39	16
Diazepam	Diazepam	38	11
Meclizine Hcl	Meclizine Hcl	38	14
Spironolactone	Spironolactone	37	11
Clonidine Hcl	Clonidine Hcl	36	12
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Finasteride	Finasteride	32	12
Glipizide Er	Glipizide	32	11
Ipratropium Bromide	Ipratropium Bromide	32	suppressed
Spiriva Handihaler	Tiotropium Bromide	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	11
Valacyclovir	Valacyclovir Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	11
Cholestyramine	Cholestyramine (With Sugar)	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Fluconazole	Fluconazole	26	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	22
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	25	suppressed
Nystatin	Nystatin	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Cilostazol	Cilostazol	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Temazepam	Temazepam	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Hydrocortisone	Hydrocortisone	23	13
Cephalexin	Cephalexin	22	18
Klor-Con M20	Potassium Chloride	22	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	22	15
Synthroid	Levothyroxine Sodium	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Verapamil Er	Verapamil Hcl	17	suppressed
Zaleplon	Zaleplon	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Glipizide	Glipizide	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error